Your Messages Inbox
Your Article Summary
See Latest ArticlesGSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
GlaxoSmithKline, 06/24/09
GlaxoSmithKline and Chroma Therapeutics Limited announced a collaboration to develop macrophage-targeted compounds using Chroma's proprietary esterase-sensitive motif technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Takeda to Continue Strategic Expansion with Operations in Brazil
Takeda Pharmaceuticals North America, 12/08/09
Forest Laboratories, Inc. to Host Analyst Meeting to Review the Company's Late-Stage Product Development Pipeline
Forest Laboratories, 12/08/09
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma
Bristol Myers-Squibb Company, 12/08/09
Article Search
Sponsor